Your session is about to expire
← Back to Search
Treatment for Kidney Cancer (ODYSSEY RCC Trial)
N/A
Recruiting
Led By Daniel George, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, every 3 months for 2 years, every 6 months for up to 36 months
Awards & highlights
Summary
ODYSSEY RCC is a prospective, observational Phase IV study is to understand the cancer management and health-related quality of life in patients with mRCC in routine real-world clinical practice in the United States, including both community and academic treatment settings.
Eligible Conditions
- Kidney Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, every 3 months for 2 years, every 6 months for up to 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, every 3 months for 2 years, every 6 months for up to 36 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in medication adherence as measured by patient report.
Change in quality of life in mRCC patients receiving therapy as measured by FACT-G
Change in quality of life in mRCC patients receiving therapy as measured by FKSI-19
+2 moreSecondary outcome measures
Concomitant glucocorticoid use
Dose holds and dose interruptions
Dosing (starting dose, dose intensity, ending dose)
+8 moreFind a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,424 Previous Clinical Trials
3,065,284 Total Patients Enrolled
Duke Clinical Research InstituteOTHER
65 Previous Clinical Trials
241,011 Total Patients Enrolled
Bristol-Myers SquibbIndustry Sponsor
2,678 Previous Clinical Trials
4,124,845 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger